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Bio-Medical
Fluorescent Quantum Dots for Biological Labeling
Fluorescence is effectively turned on by enzymes specific to cells of interest.
NASA’s Jet Propulsion Laboratory, Pasadena, California
Fluorescent semiconductor quantum
dots that can serve as “on/off” labels for
bacteria and other living cells are under-
going development. The “on/off” char-
acterization of these quantum dots
refers to the fact that, when properly de-
signed and manufactured, they do not
fluoresce until and unless they come
into contact with viable cells of biologi-
cal species that one seeks to detect. In
comparison with prior fluorescence-
based means of detecting biological
species, fluorescent quantum dots show
promise for greater speed, less complex-
ity, greater sensitivity, and greater selec-
tivity for species of interest. There are
numerous potential applications in
medicine, environmental monitoring,
and detection of bioterrorism.
The established method of using fluo-
rescent dyes to label live bacteria has sev-
eral drawbacks:
• The high autofluorescence of many
species renders many common chro-
mophores invisible;
• The anaerobic conditions under which
many bacteria live prevent proper fold-
ing of fluorescent proteins;
• Typical fluorescent dyes undergo rapid
photobleaching and thereby rapidly
cease to function as labels;
• Cells can be killed by the ultraviolet
light needed to excite fluorescence in
typical dyes used heretofore for label-
ing; and
• The addition of labeling dyes to cell
cultures often leads to high back-
ground fluorescence, and bacteria are
difficult to distinguish from debris,
even when viewed through high-reso-
lution microscopes.
When conjugated to suitable biologi-
cal molecules that quench their fluores-
cence, fluorescent semiconductor quan-
tum dots can be made to stick to the
surfaces of, or to be taken up by, specific
bacteria. To enable the on/off fluores-
cent detection of a specific bacterium,
one chooses a fluorescence-quenching
conjugate molecule that is removed by
active enzymes on or in the bacterium.
Unlike conventional labeling dyes, flu-
orescent semiconductor quantum dots
become photobleached very slowly and
can be excited by blue light, which does
not kill cells. Fluorescent semiconductor
quantum dots can be manufactured to
emit at wavelengths over a wide range —
from blue through infrared. Spectral
emission peaks of fluorescent semicon-
ductor quantum dots are narrow — typ-
ically 10 nm or less in wavelength. The
use of fluorescent semiconductor quan-
tum dots entails the following disadvan-
tages: (1) The dots are large and not al-
ways taken up by bacteria and (2) they
contain heavy metals, which may prove
toxic to organisms over long times.
Feasibility has been demonstrated in
experiments on cadmium selenide
quantum dots. First, the dots were con-
jugated to mercaptoacetic acid to render
them soluble in water. The dots were
then further conjugated to a variety of
biological compounds. Conjugation was
performed by use of a single-step car-
bodiimide reagent, which was then re-
moved by dialysis versus pure water.
Conjugation to adenine, guanine, and
tryptophan was found to quench all flu-
orescence from green-emitting quan-
tum dots, and to quench >80 percent of
the fluorescence from red-emitting
quantum dots. Fluorescence did not re-
turn upon (1) exposure to ambient light
for one week; (2) exposure to light from
a 100-W, full-spectrum Hg lamp for 30
minutes; (3) incubation with a culture
medium for 3 hours; or (4) incubation
for 3 hours with metabolically inhibited
bacterial cells [cells in a medium that
contained ethylenediaminetetraacetic
acid (EDTA), such that the cells re-
mained intact but did not metabolize].
However, upon incubation for 3 hours
in a culture medium with live bacterial
cells, fluorescence returned and could
be detected visually by color change,
spectroscopically, and by fluorescence
microscopy of individual cells.
This work was done by Gene McDonald,
Jay Nadeau, Kenneth Nealson, Michael Stor-
rie-Lombardi, and Rohit Bhartia of Caltech
for NASA’s Jet Propulsion Laboratory.
Further information is contained in a TSP
(see page 1).
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Growing Three-Dimensional Corneal Tissue in a Bioreactor
This method could help overcome the shortage of donated corneal tissue.
Lyndon B. Johnson Space Center, Houston, Texas
Spheroids of corneal tissue about 5
mm in diameter have been grown in a
bioreactor from an in vitro culture of pri-
mary rabbit corneal cells to illustrate the
production of optic cells from aggregates
and tissue. In comparison with corneal
tissues previously grown in vitro by other
techniques, this tissue approximates in-
tact corneal tissue more closely in both
size and structure. This novel three-di-
mensional tissue can be used to model
cell structures and functions in normal
and abnormal corneas. Efforts continue
to refine the present in vitro method into
one for producing human corneal tissue
to overcome the chronic shortage of
donors for corneal transplants: The
method would be used to prepare
corneal tissues, either from in vitro cul-
tures of a patient’s own cells or from a
well-defined culture from another
human donor known to be healthy.
As explained in several articles in prior
issues of NASA Tech Briefs, generally cylin-
drical horizontal rotating bioreactors
have been developed to provide nutrient-
solution environments conducive to the
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growth of delicate animal cells, with gen-
tle, low-shear flow conditions that keep
the cells in suspension without damaging
them. The horizontal rotating bioreactor
used in this method, denoted by the
acronym “HARV,” was described in
“High-Aspect-Ratio Rotating Cell-Culture
Vessel” (MSC-21662), NASA Tech Briefs,
Vol. 16, No. 5 (May, 1992), page 150.
To start a culture, the nutrient
medium in the bioreactor is inoculated
with a mixture of primary corneal cells,
including endothelial cells, epithelial
cells, and keratinocytes. Because these
cells depend on attachment, microcar-
rier beads are also introduced to provide
support. In the initial experiments, in-
soluble beads were used; alternatively,
one could use microcarriers that dis-
solve as the tissue grows, leaving only the
tissue. Another alternative would be to
introduce other cells so that the cells of
all types present could use each other
for support.
In the culture, the cells grow, multiply,
migrate into clusters, and produce an in-
tracellular matrix via the functional in-
terrelationship of cell-to-cell contact.
The cells differentiate and grow along
boundaries characteristic of normal
functional tissue. The tissue thus formed
has a layered structure similar to that of
an intact cornea.
This work was done by Glen F. Spaulding,
Thomas J. Goodwin, and Laurie Aten of
Johnson Space Center; Tacey Prewett and
Wendy S. Fitzgerald of Krug Life Sciences;
and Kim O'Connor, Delmar Caldwell, and
Karen M. Francis of Tulane University. Tu-
lane and NASA have joint undivided prop-
erty interests in this technology.
This invention is owned by NASA, and a
patent application has been filed. Inquiries
concerning nonexclusive or exclusive license
for its commercial development should be ad-
dressed to the Patent Counsel, Johnson Space
Center, (281) 483-0837. Refer to MSC-
22368.
